rupatadine has been researched along with Pruritus in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Aoki, H; Hide, M; Hirata, K; Komorita, N; Kubo, H; Suzuki, T; Tanaka, A | 1 |
Aoki, H; Hide, M; Suzuki, T; Tanaka, A | 1 |
Bartrá, J; Izquierdo, I; Mullol, J; Muñoz-Cano, R; Picado, C; Serrano, C; Valero, A | 1 |
Ferrán, M; Giménez-Arnau, A; Izquierdo, I; Maurer, M; Metz, M; Scholz, E | 1 |
Church, MK | 1 |
Brummer-Korvenkontio, H; Izquierdo, I; Karppinen, A; Reunala, T | 1 |
5 trial(s) available for rupatadine and Pruritus
Article | Year |
---|---|
[USEFULNESS OF RUPATADINE FOR PRURITUS OF PATIENTS WITH ATOPIC DERMATITIS].
Topics: Cyproheptadine; Dermatitis, Atopic; Humans; Japan; Pruritus | 2020 |
Long-term safety and efficacy of rupatadine in Japanese patients with itching due to chronic spontaneous urticaria, dermatitis, or pruritus: A 12-month, multicenter, open-label clinical trial.
Topics: Adolescent; Adult; Child; Chronic Urticaria; Cyproheptadine; Dose-Response Relationship, Drug; Eczema; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Japan; Male; Middle Aged; Pruritus; Severity of Illness Index; Sleepiness; Time Factors; Treatment Outcome; Young Adult | 2019 |
Reduction of nasal volume after allergen-induced rhinitis in patients treated with rupatadine: a randomized, cross-over, double-blind, placebo-controlled study.
Topics: Administration, Intranasal; Adolescent; Adult; Anti-Allergic Agents; Cyproheptadine; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nasal Cavity; Nasal Obstruction; Pruritus; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Rhinometry, Acoustic; Treatment Outcome | 2009 |
Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria.
Topics: Adult; Cold Temperature; Cyproheptadine; Double-Blind Method; Environmental Exposure; Female; Histamine Antagonists; Humans; Male; Middle Aged; Platelet Activating Factor; Pruritus; Treatment Outcome; Urticaria | 2010 |
Rupatadine 10 mg in the treatment of immediate mosquito-bite allergy.
Topics: Adult; Aedes; Animals; Cross-Over Studies; Cyproheptadine; Double-Blind Method; Histamine H1 Antagonists; Humans; Insect Bites and Stings; Middle Aged; Placebos; Pruritus | 2012 |
1 other study(ies) available for rupatadine and Pruritus
Article | Year |
---|---|
Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males.
Topics: Administration, Oral; Adult; Area Under Curve; Cyproheptadine; Histamine; Histamine H1 Antagonists; Humans; Injections, Intradermal; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pruritus; Skin; Young Adult | 2010 |